420 results on '"Zekeridou, Anastasia"'
Search Results
2. Neurologic manifestations of autoimmunity with immune checkpoint inhibitors
3. Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery
4. Frequency of demyelinating disease activity following immune checkpoint inhibitor cancer immunotherapy
5. Eculizumab for the treatment of glycine receptor antibody associated stiff-person syndrome
6. Phosphodiesterase 10A autoimmunity presenting as cerebellar ataxia responsive to plasma exchange: a case report
7. Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes
8. Motor-neuron-disease-like phenotype associated with IgLON5 disease
9. Seizure-Related Falls and Near Falls in LGI1-IgG Autoimmune Encephalitis
10. Immune Checkpoint Inhibitor-Associated Kelch-Like Protein-11 IgG Brainstem Encephalitis
11. High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable phage display
12. High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable phage display.
13. Blood Neurofilament Light Chain Measurements in Adults with CNS Histiocytic Neoplasms (P4-5.012)
14. Residual Symptoms, Recovery & Predictors of Long-term Sequalae After Autoimmune Encephalitis (S4.003)
15. Identification of SKOR2 IgG as a Novel Biomarker of Paraneoplastic Neurologic Syndrome (N1.001)
16. Immune Checkpoint Inhibitor-associated Kelch-like Protein-11 IgG Rhombencephalitis (P3-14.002)
17. CAMKV Autoimmune Paraneoplastic Encephalitis (N1.003)
18. Diagnostic Utility of MOG Antibody Testing in Cerebrospinal Fluid
19. Defining the CSF Cytokine and Chemokine Signature of Neurosarcoidosis (S38.009)
20. Human stem cell derived neurons and astrocytes to detect auto-reactive IgG in neurological diseases
21. Papillitis associated with IgLON5 autoimmunity: A novel clinical phenotype
22. GABAA receptor autoimmunity: A multicenter experience
23. Autoimmune/Paraneoplastic Encephalitis Antibody Biomarkers: Frequency, Age, and Sex Associations
24. Hope for patients with neuromyelitis optica spectrum disorders — from mechanisms to trials
25. Autoimmune and Paraneoplastic Encephalitis
26. MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use.
27. Paraneoplastic Calmodulin Kinase‐Like Vesicle‐Associated Protein (CAMKV) Autoimmune Encephalitis.
28. Neurological autoimmunity in patients with non‐pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles.
29. Cerebellar leptomeningeal enhancement: An imaging finding of rapidly progressive Purkinje cell cytoplasmic autoantibody type 1 paraneoplastic cerebellar syndrome
30. Behavioral and Cognitive Changes Followed by Coma
31. “Restlessness” After Cancer Diagnosis and Treatment
32. Difficulty Climbing the Stairs
33. A Patient With Headache and Progressive Tremor
34. Utility of the 2021 paraneoplastic neurologic syndromes diagnostic criteria
35. Neurological complications of immune checkpoint inhibitor cancer immunotherapy
36. Neurologic Complications of Immune Checkpoint Inhibitors in Thoracic Malignancies
37. GAD65 autoimmunity after treatment with nivolumab: a multifocal presentation
38. Use of diffusion-weighted imaging to distinguish seizure-related change from limbic encephalitis
39. CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity
40. Detection of High‐Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins
41. Identification of SKOR2 IgG as a novel biomarker of paraneoplastic neurologic syndrome
42. Hemicord White Matter Enhancement and the Croissant Sign in Cervical Spondylotic Myelopathy
43. Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease
44. Teaching NeuroImages: Linear radial periventricular enhancement in Glial Fibrillary Acidic Protein astrocytopathy
45. Tenascin‐R Autoimmunity: Isolated Tremor Reversed with Immunotherapy
46. Seizure characteristics and outcomes in patients with neurological conditions related to high‐risk paraneoplastic antibodies
47. Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria
48. Immune Checkpoint Inhibitor Associated Central Nervous System Autoimmunity
49. Neuro-Ophthalmic Complications in Patients Treated With CTLA-4 and PD-1/PD-L1 Checkpoint Blockade
50. Neurological autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.